"Blue light" cystoscopy for detection and treatment of non-muscle invasive bladder cancer

Canadian Journal of Urology

Volumn 19, Issue 2, 2012, Pages 6227-6231

  Ryan Mark, J ^a   Gelpi Hammerschmidt, Francisco ^a   Trabulsi, Edouard J ^a   Gomella, Leonard G ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Blue light cystoscopy; Fluorescence cystoscopy; Hexaminolevulinate; Non muscle invasive bladder cancer; Superficial bladder cancer

Indexed keywords

5-AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; DIAGNOSTIC AGENT; DRUG DERIVATIVE;

ARTICLE; BLADDER TUMOR; CARCINOMA IN SITU; CYSTOSCOPY; FLUORESCENCE; HUMAN; INSTRUMENTATION; METHODOLOGY; PATIENT SELECTION;

AMINOLEVULINIC ACID; CARCINOMA IN SITU; CYSTOSCOPY; FLUORESCENCE; HUMANS; PATIENT SELECTION; URINARY BLADDER NEOPLASMS;

EID: 84865828013     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Cancer Facts and Figures 2012. Atlanta: American Cancer Society 2012.
2. Herr H. Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. J Urol 2000;163(1):60-62.
3. Jocham D, Stepp H, Waidelich R. Photodynamic diagnosis in urology: state-of-the-art. Eur Urol 2008;53(6):1138-1148.
4. Photodynamic D-Light C system [Instruction Manual] El Segundo, CA: Karl Storz Endoscopy-America, Inc.; 2004.
5. Cysview™ [Package Insert] Princeton, NJ: Photocure US; 2011.
6. Witjes JA, Redorta JP, Jacqmin D et al. Hexaminolevulinateguided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle invasive bladder cancer: review of the evidence and recommendations. Eur Urol 2010;57(4):607-614.
7. Fradet Y, Grossman HB, Gomella LG et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol 2007;178(1): 68-73.
8. Stenzl A, Burger M, Fradet Y et al. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. J Urol 2010;184(5):1907-1913.
9. Hermann GG, Mogensen K, Carlsson S, Marcussen N, Duun S. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study. BJU Int 2011;108(8 Pt 2):E297-E303.
10. Babjuk M, Oosterlinck W, Sylvester R et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 2011;59(6):997-1008.